Literature DB >> 1519858

Factors associated with tuberculin reactivity among the foreign-born in Montreal.

R Menzies1, B Vissandjee, D Amyot.   

Abstract

Because tuberculosis among the foreign-born is of increasing importance in North America, it has recently been recommended that newly arriving immigrants be tuberculin tested and preventive therapy given to all those with significant reactions. The factors affecting the prevalence of tuberculin reactions were assessed in a community-based tuberculin survey among foreign-born schoolchildren and young adults. Of 1,198 foreign-born who were tuberculin tested, 32.4% had significant tuberculin reactions. False-positive tuberculin reactions due to sensitivity to purified protein derivative (PPD)-B (for Mycobacterium avium) were uncommon and those due to BCG vaccination of importance only among immigrants from countries with low tuberculosis rates. Tuberculin reactions of 10+ mm were associated with tuberculosis rates in the country of origin (p less than or equal to 0.001), age when immigrated (p less than or equal to 0.001), bacillus Calmette-Guérin (BCG) vaccination (p less than or equal to 0.01), and residence in poorer neighborhoods in Montreal (p less than or equal to 0.001), but not with number of years resident in Canada. The booster phenomenon, seen in 16% of those undergoing two-step testing, was most strongly associated with prior BCG vaccination (p less than or equal to 0.001) and also with tuberculosis rates in the country of origin (p less than or equal to 0.08), age of immigration (p less than or equal to 0.01), and number of years resident in Canada (p less than or equal to 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1992        PMID: 1519858     DOI: 10.1164/ajrccm/146.3.752

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  16 in total

Review 1.  Tuberculosis: 10. Prevention.

Authors:  D Menzies; T N Tannenbaum; J M FitzGerald
Journal:  CMAJ       Date:  1999-09-21       Impact factor: 8.262

2.  Screening immigrants to Canada for tuberculosis: chest radiography or tuberculin skin testing?

Authors:  Dick Menzies
Journal:  CMAJ       Date:  2003-11-11       Impact factor: 8.262

3.  Screening and treatment of immigrants and refugees to Canada for tuberculosis: Implications of the experience of Canada and other industrialized countries.

Authors:  R E Thomas; B Gushulak
Journal:  Can J Infect Dis       Date:  1995-09

Review 4.  A systematic review on TST and IGRA tests used for diagnosis of LTBI in immigrants.

Authors:  Jonathon R Campbell; Jane Krot; Kevin Elwood; Victoria Cook; Fawziah Marra
Journal:  Mol Diagn Ther       Date:  2015-02       Impact factor: 4.074

5.  Latent tuberculosis infection screening in immigrants to low-incidence countries: a meta-analysis.

Authors:  Jonathon R Campbell; Wenjia Chen; James Johnston; Victoria Cook; Kevin Elwood; Jane Krot; Fawziah Marra
Journal:  Mol Diagn Ther       Date:  2015-04       Impact factor: 4.074

Review 6.  Current concepts in the management of tuberculosis.

Authors:  Irene G Sia; Mark L Wieland
Journal:  Mayo Clin Proc       Date:  2011-04       Impact factor: 7.616

7.  Performance of a rapid strip test for the serologic diagnosis of latent tuberculosis in children.

Authors:  Songsri Kasempimolporn; Wichit Thaveekarn; Phirangkul Kerdpanich; Urailak Skulpichetrat; Orawan Saekhow; Supatsorn Boonchang; Thipchuta Bharnthong; Visith Sitprija
Journal:  J Clin Diagn Res       Date:  2015-01-01

8.  Expanding the epidemiologic profile: risk factors for active tuberculosis in people immigrating to Ontario.

Authors:  W L Wobeser; L Yuan; M Naus; P Corey; J Edelson; N Heywood; D L Holness
Journal:  CMAJ       Date:  2000-10-03       Impact factor: 8.262

9.  Evaluation of a tuberculosis screening program for high-risk students in Toronto schools.

Authors:  L Yuan; E Richardson; P R Kendall
Journal:  CMAJ       Date:  1995-10-01       Impact factor: 8.262

10.  Community-based tuberculin screening in Montreal: a cost-outcome description.

Authors:  N Adhikari; R Menzies
Journal:  Am J Public Health       Date:  1995-06       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.